Alembic Pharma - Q4FY13 Result Preview - Angel Broking

Alembic Pharmaceuticals, for the, 4QFY2013 is expected to post a muted set of numbers. The top line is expected to grow by only 2.4% to Rs. 349cr, mainly on back of low growth in exports, on back of capacity constraints. The OPM is expected to come to end the period at 14.6%, an expansion of 300bps. In spite, of the same adjusted Net Profit is expected to grow by 7.4% yoy to end the period at Rs. 18.8cr, on back of higher taxation.

We recommend a accumulate with a price target of Rs. 122.

Source : Equity Bulls

Keywords